Our results also revealed that the expression of BRD2, BRD3, and BRD4 was altered by 5%, 5%, and 12%, respectively, in patients with ACC, with the type of genetic alteration mainly including high and low RNA levels. Here, BRD4 is linked to adrenal cortex carcinoma.